Literature DB >> 19432010

Effects of chicken anemia virus and infectious bursal disease virus in commercial chickens.

H Toro1, V L van Santen, F J Hoerr, C Breedlove.   

Abstract

The effects of chicken anemia virus (CAV) and infectious bursal disease virus (IBDV) coinfection in commercial layer-type and meat-type (broiler) chickens with specific maternal immunity were evaluated. In addition, the broiler progeny used had been vaccinated in ovo against IBDV. Layer chickens were inoculated intramuscularly on day 3 of age with CAV and orally on day 7 of age with an IBDV standard strain (APHIS). Broiler chickens were exposed to CAV and/or an IBDV variant strain (AL2) via the drinking water on days 3 and 14 of age. Following CAV and IBDV inoculation neither mortality nor overt clinical disease was observed in any layer or broiler group. In spite of maternal immunity against both IBDV and CAV, mean hematocrits of all layer groups inoculated with CAV (CAV, CAV + APHIS) were lower than uninfected chickens. IBDV APHIS alone or in combination with CAV did not affect the layer weight gain. However, on day 30 of age and concomitantly with maternal antibody decay, bursa lymphocyte depletion became evident in CAV + APHIS-infected layer chickens. These birds (CAV + APHIS) also seroconverted to IBDV on day 35 of age. CAV persisted at low levels in the layer chickens throughout the experimental period in CAV- and CAV+APHIS-infected chickens. Similarly, infected broiler chickens did not show changes in weight gain. Compared to CAV-infected or uninfected controls, CAV+AL2- and AL2-infected broiler chickens showed significant lymphocyte depletion in the bursa as assessed both by bursal indices and histomorphometry. Broilers also seroconverted to IBDV after day 30 of age confirming that bursal lymphocyte depletion was due to IBDV resuming replication. Thymus histomorphometry revealed significant lymphocyte depletion in all infected broiler groups at 30 days of age, but only in CAV+AL2-infected broiler chickens at 41 days of age, suggesting that IBDV infection delayed repopulation of the thymus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432010     DOI: 10.1637/8408-071408-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  6 in total

1.  A 5-year study of the incidence and economic impact of variant infectious bursal disease viruses on broiler production in Saskatchewan, Canada.

Authors:  Tara Zachar; Shelly Popowich; Bob Goodhope; Tennille Knezacek; Davor Ojkic; Philip Willson; Khawaja Ashfaque Ahmed; Susantha Gomis
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  Infectious bursal disease: outbreak investigation, molecular characterization, and vaccine immunogenicity trial in Ethiopia.

Authors:  Aregitu Mekuriaw; Molalegne Bitew; Esyas Gelaye; Bedaso Mamo; Gelagay Ayelet
Journal:  Trop Anim Health Prod       Date:  2017-06-15       Impact factor: 1.559

3.  Association of increased rate of condemnation of broiler carcasses due to hepatic abnormalities with immunosuppressive diseases in the broiler chicken industry in Saskatchewan.

Authors:  Keyvan Amini; Tara Zachar; Shelly Popowich; Tennille Knezacek; Bob Goodhope; Philip Willson; Susantha Gomis
Journal:  Can J Vet Res       Date:  2015-10       Impact factor: 1.310

4.  Human gyrovirus DNA in human blood, Italy.

Authors:  Fabrizio Maggi; Lisa Macera; Daniele Focosi; Maria Linda Vatteroni; Ugo Boggi; Guido Antonelli; Marc Eloit; Mauro Pistello
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

5.  Respiratory viruses and torque teno virus in adults with acute respiratory infections.

Authors:  Afiono Agung Prasetyo; Martinus Nuherwan Desyardi; Jimmy Tanamas; Seiji Kageyama; Hiroki Chikumi; Eiji Shimizu
Journal:  Intervirology       Date:  2015       Impact factor: 1.763

6.  Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition.

Authors:  Li Li; Tereza Kubasová; Ivan Rychlik; Frederic J Hoerr; Silke Rautenschlein
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.